Qiming Venture Partners and Six Portfolio Companies Named to 2025 Investment Institution Soft Power Rankings
By constructing a localized private equity valuation framework, FOFWEEKLY aims to advance industry standardization and ultimately establish industry benchmarks that carry social-value leadership.
Recently, the 2025 Investment Firm Soft Power Rankings were officially released. The list comprises LP rankings, GP rankings, and enterprise rankings. Qiming Venture Partners and six of its portfolio companies were named to the list.
Qiming Venture Partners ranked in the top 5 GPs and the top 20 in AI and digital economy.
Qiming Venture Partners
Selected for
Top 5 GPs
Top 20 in AI and Digital Economy
Qiming Venture Partners portfolio companies Zhipu AI, Biren Technology, Mech-Mind Robotics, Prismlab, DeepWay, and Galaxy Universal were named to the Future Industries Top 50.
Zhipu AI, Biren Technology, Mech-Mind Robotics
Prismlab, DeepWay, Galaxy Universal
Selected for
Future Industries Top 50
· 2025 Investment Firm Soft Power Rankings
Based on a panoramic survey of China's equity investment market, FOFWEEKLY identifies value creators with sustained evolutionary capacity in the new economic cycle. Grounded in a soft power evaluation model, the rankings adhere strictly to the "three public principles" and a quality-plus-quantity assessment framework, with secondary calibration of leading institutions. The goal is to establish a localized private equity valuation benchmark, advance industry standardization, and ultimately identify industry benchmarks with socially valuable leadership impact.
This year's evaluation system focuses on the following dimensions:
1. Value Creation. Emphasizes the diligence, risk management, and track record validation of an institution's core team. The rankings primarily weigh performance, risk control mechanisms, and value added to portfolio companies;
2. Market Influence. Focuses on the degree of market and industry attention, influence, and rallying power of investment institutions. The rankings primarily weigh fundraising effectiveness, investment effectiveness, and brand management;
3. Service and Empowerment. Focuses on an institution's service and empowerment capabilities for LPs and portfolio companies. The rankings primarily weigh investor services, government relations and services, post-investment empowerment, and post-investment team;
4. Social Responsibility. Evaluates an institution's sustainable development impact on the environment and society through its investments, with particular attention to investment practices in rural revitalization and ESG. The rankings primarily weigh ESG and responsible investment initiatives.
FOFWEEKLY notes that 2025 may be a year of "rebirth" for the equity investment industry, with the market at a critical juncture of structural recovery. Since the beginning of the year, venture capital activity has rebounded markedly, and the M&A market has also encountered new opportunities. Frontier sectors such as artificial intelligence and robotics have remained intensely hot, becoming core focus areas for investment institutions and rapidly igniting primary market investment confidence.
For investment institutions, how to find new development paradigms from past successful paths has become a central industry topic; at the same time, clearer investment strategies and efficient exit capabilities are also crucial. In this process, the soft power of investment institutions has become the core element for adapting to market transformation and building new competitive advantages.
Source | FOFWEEKLY
Past Highlights
Qiming Honors | Qiming Venture Partners' Duane Kuang and Shiyu Wang Win Two Awards at FOFWEEKLY Equity Investment Industry Figures Awards Qiming Stars | Multiple Qiming Venture Partners Portfolio Companies Named to 2025 Shanghai Specialized and Innovative SMEs List and Innovative SMEs List (Second Batch) Qiming Stars | 7 Qiming Venture Partners Portfolio Companies Named to QbitAI Research Institute 2025H1 AI 100 Product Rankings
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total committed capital reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in the Technology and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), GenScript ProBio (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.